Form 4: Director R. Alexandra Keith Acquires Thermo Fisher Shares
Statement of Changes in Beneficial Ownership
Thermo Fisher Scientific director R. Alexandra Keith acquired 499 shares of common stock as part of a compensation grant.
Summary
- Director R. Alexandra Keith acquired 499 shares of Thermo Fisher Scientific (TMO) common stock.
- The transaction occurred on May 20, 2026.
- The shares were acquired at a price of $0, indicating a stock grant or equity compensation award.
- Following this transaction, the director's total beneficial ownership is 2,602 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director equity compensation.
Positives
- Increased alignment between the director and shareholder interests through additional equity ownership.
Negatives
- None identified.
Risks
- None identified.
Future Outlook
Not applicable as this is a routine disclosure of director equity compensation.
Industry Context
StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to incentivize long-term performance and align leadership with shareholder value.
Comparison to Industry Standards
- The acquisition is consistent with standard director compensation packages for large-cap life sciences companies.
Stakeholder Impact
- Minimal impact on shareholders as this represents a standard equity grant to a director.
Next Steps
- None identified.
Key Dates
| Date | Description |
|---|---|
| 05/20/2026 | Date of the equity acquisition transaction. |
| 05/22/2026 | Date the Form 4 was signed and filed. |
Keywords
Thermo Fisher Scientific, TMO, Form 4, Insider Trading, Director Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.